Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down1.35% Nasdaq Down1.12%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS

6.32 Down 0.09(1.33%) 4:00PM EDT|After Hours : 6.32 0.00 (0.00%) 4:32PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.5
Mean Recommendation (last week):2.5
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:8.14
Median Target:9.00
High Target:12.00
Low Target:4.00
No. of Brokers:7

Data provided by Thomson/First Call
Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 31, 2011Stifel NicolausInitiated Buy
Oct 18, 2010JMP SecuritiesInitiated Mkt Perform
Oct 5, 2010Barclays CapitalInitiated Overweight
Apr 7, 2010William BlairInitiated Outperform
Mar 21, 2010Brean MurrayUpgradeHoldBuy
Oct 12, 2009Wedbush MorganUpgradeNeutralOutperform
Apr 28, 2009Roth CapitalUpgradeHoldBuy
Apr 20, 2009Wedbush MorganInitiated Buy
Mar 19, 2009LazardInitiated Hold
Feb 25, 2009Merriman Curhan FordInitiated Buy

More Upgrades & Downgrades for HALO

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1222
Buy4333
Hold2222
Underperform0000
Sell1111

Data provided by Thomson/First Call


Currency in USD.